Found: 260
Select item for more details and to access through your institution.
Prospective phase II trial of everolimus in PIK3CA amplification/mutation and/or PTEN loss patients with advanced solid tumors refractory to standard therapy.
- Published in:
- 2017
- By:
- Publication type:
- journal article
c-MET Overexpression in Colorectal Cancer: A Poor Prognostic Factor for Survival.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Phase I Trial of Anti-MET Monoclonal Antibody in MET-Overexpressed Refractory Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
PD-L1 expression in gastric cancer determined by digital image analyses: pitfalls and correlation with pathologist interpretation.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The prevalence of homologous recombination deficiency (HRD) in various solid tumors and the role of HRD as a single biomarker to immune checkpoint inhibitors.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 9, p. 2427, doi. 10.1007/s00432-021-03781-6
- By:
- Publication type:
- Article
Value of FGFR2 expression for advanced gastric cancer patients receiving pazopanib plus CapeOX (capecitabine and oxaliplatin).
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2016, v. 142, n. 6, p. 1231, doi. 10.1007/s00432-016-2143-2
- By:
- Publication type:
- Article
The different efficacy of gefitinib or erlotinib according to epidermal growth factor receptor exon 19 and exon 21 mutations in Korean non-small cell lung cancer patients.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2011, v. 137, n. 4, p. 687, doi. 10.1007/s00432-010-0928-2
- By:
- Publication type:
- Article
Prediction of epithelial-to-mesenchymal transition molecular subtype using CT in gastric cancer.
- Published in:
- European Radiology, 2022, v. 32, n. 1, p. 1, doi. 10.1007/s00330-021-08094-3
- By:
- Publication type:
- Article
Effect of Vemurafenib on the Pharmacokinetics of a Single Dose of Tizanidine (a CYP1A2 Substrate) in Patients With BRAF<sup>V600</sup> Mutation–Positive Malignancies.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 5, p. 651, doi. 10.1002/cpdd.788
- By:
- Publication type:
- Article
ESRP1-regulated isoform switching of LRRFIP2 determines metastasis of gastric cancer.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-33786-9
- By:
- Publication type:
- Article
Pembrolizumab or pembrolizumab plus chemotherapy versus standard of care chemotherapy in patients with advanced gastric or gastroesophageal junction adenocarcinoma: Asian subgroup analysis of KEYNOTE-062.
- Published in:
- Japanese Journal of Clinical Oncology, 2023, v. 53, n. 3, p. 221, doi. 10.1093/jjco/hyac188
- By:
- Publication type:
- Article
Detection of Fusion Genes Using a Targeted RNA Sequencing Panel in Gastrointestinal and Rare Cancers.
- Published in:
- Journal of Oncology, 2020, p. 1, doi. 10.1155/2020/4659062
- By:
- Publication type:
- Article
Influential factors for the collection of peripheral blood stem cells and engraftment in acute myeloid leukemia patients in first complete remission.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Tuberculosis in hematopoietic stem cell transplant recipients in Korea.
- Published in:
- 2004
- By:
- Publication type:
- journal article
PIK3CA mutation subtype delineates distinct immune profiles in gastric carcinoma.
- Published in:
- Journal of Pathology, 2023, v. 260, n. 4, p. 443, doi. 10.1002/path.6134
- By:
- Publication type:
- Article
Synergistic Effects of Combination Therapy with AKT and mTOR Inhibitors on Bladder Cancer Cells.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 8, p. 2825, doi. 10.3390/ijms21082825
- By:
- Publication type:
- Article
Preexisting oncogenic events impact trastuzumab sensitivity in ERBB2-amplified gastroesophageal adenocarcinoma.
- Published in:
- Journal of Clinical Investigation, 2014, v. 124, n. 12, p. 5145, doi. 10.1172/JCI75200
- By:
- Publication type:
- Article
Phase II trial of epidermal growth factor ointment for patients with Erlotinib-related skin effects.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A randomized study of the efficacy and safety of transdermal granisetron in the control of nausea and vomiting induced by moderately emetogenic chemotherapy in Korean patients.
- Published in:
- Supportive Care in Cancer, 2015, v. 23, n. 6, p. 1769, doi. 10.1007/s00520-014-2507-6
- By:
- Publication type:
- Article
KIT amplification and gene mutations in acral/mucosal melanoma in Korea.
- Published in:
- APMIS, 2011, v. 119, n. 6, p. 330, doi. 10.1111/j.1600-0463.2011.02737.x
- By:
- Publication type:
- Article
Excision repair cross-complementation group 1 (ERCC1) expression in advanced urothelial carcinoma patients receiving cisplatin-based chemotherapy KIM et al. ERCC1 IN ADVANCED UROTHELIAL CARCINOMA.
- Published in:
- APMIS, 2010, v. 118, n. 12, p. 941, doi. 10.1111/j.1600-0463.2010.02648.x
- By:
- Publication type:
- Article
Prognostic role of insulin-like growth factor receptor-1 expression in small cell lung cancer.
- Published in:
- APMIS, 2009, v. 117, n. 12, p. 861, doi. 10.1111/j.1600-0463.2009.02545.x
- By:
- Publication type:
- Article
Expression of activated signal transducer and activator of transcription 3 predicts poor clinical outcome in gastric adenocarcinoma.
- Published in:
- APMIS, 2009, v. 117, n. 8, p. 598, doi. 10.1111/j.1600-0463.2009.02512.x
- By:
- Publication type:
- Article
L1 cell adhesion molecule as a predictor for recurrence in pulmonary carcinoids and large-cell neuroendocrine tumors.
- Published in:
- APMIS, 2009, v. 117, n. 2, p. 140, doi. 10.1111/j.1600-0463.2009.02433.x
- By:
- Publication type:
- Article
Xerna™ TME Panel is a machine learning-based transcriptomic biomarker designed to predict therapeutic response in multiple cancers.
- Published in:
- Frontiers in Oncology, 2023, p. 01, doi. 10.3389/fonc.2023.1158345
- By:
- Publication type:
- Article
Accuracy of MRI for estimating residual tumor size after neoadjuvant chemotherapy in locally advanced breast cancer: Relation to response patterns on MRI.
- Published in:
- Acta Oncologica, 2007, v. 46, n. 7, p. 996, doi. 10.1080/02841860701373587
- By:
- Publication type:
- Article
Hepatocellular carcinoma patients with high circulating cytotoxic T cells and intra-tumoral immune signature benefit from pembrolizumab: results from a single-arm phase 2 trial.
- Published in:
- Genome Medicine, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13073-021-00995-8
- By:
- Publication type:
- Article
Comprehensive molecular characterization of gastric cancer patients from phase II second-line ramucirumab plus paclitaxel therapy trial.
- Published in:
- Genome Medicine, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13073-021-00826-w
- By:
- Publication type:
- Article
Determining Which Patients Require Preoperative Pelvic Radiotherapy Before Curative-Intent Surgery and/or Ablation for Metastatic Rectal Cancer.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 7, p. 4197, doi. 10.1245/s10434-022-11592-3
- By:
- Publication type:
- Article
ASO Visual Abstract: Determining Which Patients Require Preoperative Pelvic Radiotherapy Before Curative Intent Surgery and/or Ablation for Metastatic Rectal Cancer.
- Published in:
- 2022
- By:
- Publication type:
- Abstract
ASO Video Abstract: Microsatellite Instability and the Effectiveness of Adjuvant Treatment in pT1N1 Gastric Cancer—A Multi-cohort Study.
- Published in:
- 2021
- By:
- Publication type:
- Abstract
Microsatellite Instability and Effectiveness of Adjuvant Treatment in pT1N1 Gastric Cancer: A Multicohort Study.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2021, v. 28, n. 13, p. 8908, doi. 10.1245/s10434-021-10084-0
- By:
- Publication type:
- Article
Adjuvant Chemotherapy Versus Chemoradiotherapy Versus Surgery Alone for Early Gastric Cancer with One or Two Lymph Node Metastasis.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2018, v. 25, n. 6, p. 1616, doi. 10.1245/s10434-018-6434-5
- By:
- Publication type:
- Article
CD151 Overexpression is Associated with Poor Prognosis in Patients with pT3 Gastric Cancer.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2014, v. 21, n. 4, p. 1099, doi. 10.1245/s10434-013-3339-1
- By:
- Publication type:
- Article
Prediction of Disease-free Survival in Hepatocellular Carcinoma by Gene Expression Profiling.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2013, v. 20, n. 12, p. 3747, doi. 10.1245/s10434-013-3070-y
- By:
- Publication type:
- Article
Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes.
- Published in:
- Nature Medicine, 2015, v. 21, n. 5, p. 449, doi. 10.1038/nm.3850
- By:
- Publication type:
- Article
Tumor-promoting macrophages prevail in malignant ascites of advanced gastric cancer.
- Published in:
- Experimental & Molecular Medicine EMM, 2020, v. 52, n. 12, p. 1976, doi. 10.1038/s12276-020-00538-y
- By:
- Publication type:
- Article
Gastroenteropancreatic neuroendocrine tumors: Incidence and treatment outcome in a single institution in Korea.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2011, v. 7, n. 3, p. 293, doi. 10.1111/j.1743-7563.2011.01423.x
- By:
- Publication type:
- Article
Extraosseous osteosarcoma: Single institutional experience in Korea.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2010, v. 6, n. 2, p. 126, doi. 10.1111/j.1743-7563.2010.01278.x
- By:
- Publication type:
- Article
A phase I study of IMC-001, a PD-L1 blocker, in patients with metastatic or locally advanced solid tumors.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 6, p. 1624, doi. 10.1007/s10637-021-01078-6
- By:
- Publication type:
- Article
Phase I trial and pharmacokinetic study of tanibirumab, a fully human monoclonal antibody to vascular endothelial growth factor receptor 2, in patients with refractory solid tumors.
- Published in:
- Investigational New Drugs, 2017, v. 35, n. 6, p. 782, doi. 10.1007/s10637-017-0463-y
- By:
- Publication type:
- Article
Treatment outcome of PD-1 immune checkpoint inhibitor in Asian metastatic melanoma patients: correlative analysis with PD-L1 immunohistochemistry.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 6, p. 677, doi. 10.1007/s10637-016-0373-4
- By:
- Publication type:
- Article
Erratum to: Effect of simvastatin plus cetuximab/irinotecan for KRAS mutant colorectal cancer and predictive value of the RAS signature for treatment response to cetuximab.
- Published in:
- 2015
- By:
- Publication type:
- Erratum
Favorable clinical efficacy of cytotoxic chemotherapy in patients with progressive desmoid tumors: a retrospective real-world study.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 6, p. 853, doi. 10.1007/s10147-024-02506-2
- By:
- Publication type:
- Article
A phase I trial of S-1 with oxaliplatin in patients with relapsed and metastatic colorectal cancer.
- Published in:
- International Journal of Colorectal Disease, 2009, v. 24, n. 11, p. 1311, doi. 10.1007/s00384-009-0758-3
- By:
- Publication type:
- Article
Frequent Paternal Mitochondrial Inheritance and Rapid Haplotype Frequency Shifts in Copepod Hybrids.
- Published in:
- Journal of Heredity, 2022, v. 113, n. 2, p. 171, doi. 10.1093/jhered/esab068
- By:
- Publication type:
- Article
Comprehensive Molecular Characterization of Soft Tissue Sarcoma for Prediction of Pazopanib-Based Treatment Response.
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 2, p. 671, doi. 10.4143/crt.2022.251
- By:
- Publication type:
- Article
A Phase II Study of Preoperative Chemoradiotherapy with Capecitabine Plus Simvastatin in Patients with Locally Advanced Rectal Cancer.
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 1, p. 189, doi. 10.4143/crt.2021.1527
- By:
- Publication type:
- Article
Whole-Genome and Transcriptome Sequencing Identified NOTCH2 and HES1 as Potential Markers of Response to Imatinib in Desmoid Tumor (Aggressive Fibromatosis): A Phase II Trial Study.
- Published in:
- Cancer Research & Treatment, 2022, v. 54, n. 4, p. 1240, doi. 10.4143/crt.2021.1194
- By:
- Publication type:
- Article
Genomic Sequencing for Bladder Urothelial Carcinoma and Its Clinical Implications for Immunotherapy.
- Published in:
- Cancer Research & Treatment, 2022, v. 54, n. 3, p. 894, doi. 10.4143/crt.2021.854
- By:
- Publication type:
- Article